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Abstract
Background: The enzyme 5-lipoxygenase (5LO) has been implicated in a variety of neurological and psychiatric disorders
including anxiety. Knockout of 5LO has previously been shown to alter anxiety-like behavior in mice at a young age but the
effect of 5LO knockout on older animals has not been characterized.
Methodology/Principal Findings: Here we used the elevated plus maze behavioral paradigm to measure anxiety-like
behavior in female mice lacking 5LO (5LO-KO) at three different ages. Adolescent 5LO-KO animals did not significantly differ
from wild-type (WT) animals in anxiety-like behavior. However, adult and older mice exhibited increased anxiety-like
behavior compared to WT controls.
Conclusions: These results indicate that 5LO plays a role in the development of the anxiety-like phenotype in an age-
dependent manner in female mice. Future work should further investigate this interaction as 5LO may prove to be an
important molecular target for the development of novel anxiolytic therapies.
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Introduction
5-lipoxygenase (5LO) is an enzyme that converts arachidonic
acid to leukotriene metabolites, fatty acid signaling molecules that
are important contributors to the pathophysiology of allergy,
asthma and inflammation [1–3]. However, 5LO is also widely
expressed in the central nervous system and emerging work
suggests 5LO may play a role in neurological and psychiatric
disorders. 5LO contributes to Alzheimer’s disease pathology, prion
protein toxicity as well as multiple sclerosis demyelination [4–6].
5LO levels are altered in the brains of suicide victims and its
pharmacologic inhibition has been shown to potentiate antide-
pressant activity in mice [7,8]. 5LO has also been implicated as an
important molecular target in anxiety, with knockout of 5LO
(5LO-KO) reported to decrease anxiety-like behavior at a young
age in male mice [9]. However, anxiety-like behavior in 5LO-KO
mice has not been otherwise characterized. Clinical data indicates
that anxiety disorders are more common in women and that
lifetime prevalence of anxiety disorders changes with age, reaching
a peak in adolescence to early adulthood [10]. 5LO is known to
increase in an age-dependent manner in several brain regions and
has been conjectured to serve a potential biological link between
stressors and the development of neuropsychiatric illness [11–13].
Therefore, in this study we asked the question of what effect 5LO
knockout (5LO-KO) has on anxiety-like behavior in mice at
different ages. To this end, we used the elevated plus maze
paradigm to compare the behaviors of wild-type (WT) and female
5LO-KO mice at 3, 6 and 12 months of age.
Our findings show that compared with WT, 5LO-KO mice
manifest an age-dependent increase in anxiety-like behavior as
measured by this paradigm.
Understanding the interactions between the 5LO pathway and
the anxiety phenotype may provide the basis for a clinical




Female wild-type C57BL/6 (WT; The Jackson Laboratory)
and 5LO knockout mice (5LO-KO; The Jackson Laboratory)
aged 3, 6, and 12 months were used for this study. All mice were
housed on a 12 hours light/dark cycle in the Medical Research
Building at the Temple University Health Sciences Campus,
which is fully accredited by the Association for the Assessment
and Accreditation of Laboratory Animal Care International.
Standard mouse chow and water were provided ad libitum.
Animal procedures were conducted in accordance with the
National Institute of Health guidelines for the use of experimental
animals and were approved by the Temple University’s Animal
Care and Use Committee.
Elevated plus maze
All animals were pre-handled for 3 days prior to testing. They
were tested in a randomized order, and all tests were conducted
by an experimenter blinded to the genotype. Anxiety-like
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paradigm. The elevated plus maze (SD Instruments, San
Diego, CA) utilized in this study was made of beige high density,
non-porous plastic in the form of a plus sign with four arms of
equal length (32 cm) and width (5 cm) elevated 40 cm off the
ground. Two arms were closed off with 15.5-cm-high walls and
two open arms had 0.5-cm-high ledges. Arms extended form a
central square platform (565 cm). Room lighting was adjusted
such that closed arm light levels were maintained at ,160 lux
and open arm light levels were maintained at approximately
,200 lux. Each mouse was placed in center square facing a
closed arm and was allowed to freely explore for 10 min while
being video recorded. The elevated plus maze was cleaned with
30% ethanol and allowed to dry following each behavioral test.
An entry was counted when the mouse had all four paws in an
arm.
Statistical analysis
Data are presented as the mean 6 standard error of the mean.
Percent of time spent in closed and open arms [(total time in arms/
600 s) * 100] and percent of closed and open arm entries [(total
arm entries/total entries) * 100] were calculated for each animal.
The unpaired two-tailed student -t-test with an alpha of P,0.05
was used to define significance.
Results
No effect on anxiety in adolescent mice lacking 5LO
First, we investigated whether 5LO knockout leads to changes in
anxiety-like behavior in 3 month-old mice. As shown in Figure 1,
no statistically significant differences were observed in the
percentage of closed (WT: 55.7.2 %+12; 5LO-KO: 70%+3;
P,0.2) or open arm entries (WT: 44.3%+12.2; 5LO-KO: 30%+3;
P,0.2) between the two groups of mice. Similar results were
observed when the total entries (WT: 39.5+2.1; 5LOKO: 38+4;
P,0.6), and the percentage time spent in closed (WT: 54.3%+3.8;
5LO-KO: 68.8%+6.5; P,0.1) or open arms (WT: 16.6%+2.7;
5LO-KO: 15.2%+2.4; P,0.7) were evaluated (Fig. 1).
Adult mice lacking 5LO exhibit greater anxiety-like
behavior than wild type
Because anxiety disorders commonly develop in early and mid-
adulthood, we asked whether 5LOKO mice at 6 months of age
would display an anxiety-like phenotype different from adolescent
mice. As shown in Figure 2, 5LO-KO mice spent statistically
significant more time in the closed arms (WT: 44.8%+10.8; 5LO-
KO: 77.3%+4.8; P,0.03), less time in the open arms (WT:
35.2%+8.3;5LO-KO: 9.4%+3.6; P,0.03), and had lower total
number of entries (WT: 28+2.2;5LO-KO: 15.3+1.9; P,0.003).
Figure 1. Elevated plus maze behavior in 3 month-old mice. Percentage of total entries into the closed arm (A), open arm (B), total arm entries
(C), percentage of total time spent in closed (D) and open arm (E). No difference was detected in any parameter between wild type (WT) (open bars)
and 5LO-KO mice (closed bars) (WT, n=6; 5LO-KO n=3).
doi:10.1371/journal.pone.0029448.g001
5-Lipoxygenase and Anxiety
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e29448However, no significant difference in the percentage of entries into
the closed (WT: 55.3%+6.4; 5LO-KO: 76.0%+6.8; P,0.06) or
open arms (WT: 44.7%+6.4; 5LO-KO: 24.0%+6.8; P,0.06) was
observed (Fig. 2).
Mice lacking 5LO continue to exhibit anxiety-like
behavior in late adulthood
Finally we investigated how the anxiety-like behavior is affected
by 5LO knockout through late adulthood. As shown in Figure 3,
12-month-old 5LO-KO mice entered the closed arms significantly
more (WT: 50.4 %+4.1; 5LO-KO: 67.7%+4.1: P,0.02) and the
open arms significantly less (WT: 49.6%+4.1; 5LO-KO:
32.3%+4.1; P,0.02) than WT mice. Additionally, 5LO-KO mice
spent significantly more time in the closed arms (WT: 46.3
%+10.4; 5LO-KO: 83.3%+5.1; P,0.02) and significantly less time
in the open arms (WT: 36.5 %+7.57; 5LO-KO: 10.2% + 3.8;
P,0.03). However, at this age no statistically significant difference
was found in the number of total entries between genotypes (WT:
19 + 3.5; 5LOKO: 18.25 + 3.6: P,0.8) (Fig. 3).
Discussion
The goal of the current study was to determine whether mice
with the genetic absence of 5LO, which appear normal when left
unchallenged, manifest modified anxiety-like behavior as mea-
sured by the elevated plus maze and whether there exists an age-
dependent effect.
The elevated plus maze draws out competing preferences in
mice between exploring novel environments (i.e., activity in open
arms) and being in a protected environment (i.e., activity in closed
arms). Low anxiety behavior is usually reflected by higher number
of entries and/or length of time spent in open arms, while higher
entries and/or time spent in closed arms corresponds to a pro-
anxiety phenotype [14,15].
In our study, we found that 5LO-KO animals did not differ
from the WT cohorts at 3 months of age in any parameter of
anxiety-like behavior as measured by this type of maze. However,
at 6 months of age, differences in anxiety were apparent between
groups as 5LO-KO spent more time in the closed arms and spent
less time in the open arms than WT mice, reflecting a pro-anxiety
behavior. By 12 months, 5LO-KO animals, in addition to
spending greater time in the closed arm and less time in the open
arms, also entered the closed arms more and entered the open
arms less than WT animals.
Differences in total number of arm entries in the elevated plus
maze as those we found at 6 months of age between WT and 5LO-
KO animals may indicate that some locomotor differences exist
between mice groups, which could potentially result in artifactual
anxiety-like behavior. However, we believe that general locomotor
differences are not the cause for the increased anxiety phenotype
Figure 2. Elevated plus maze behavior in 6 mo old mice. Percentage of total entries into the closed arm (A), open arm (B), total arm entries (C)
and percentage of total time spent in closed (D) and open arm (E). 5LO-KO mice (closed bars) spent more time in the closed arm and less time in the
open arm than wild type (WT) mice (open bars). 5LO-KO animals also entered less total arms than WT. (WT, n=4; 5LO-KO, n=4; P,0.05).
doi:10.1371/journal.pone.0029448.g002
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in both WT mice and 5LO-KO mice from 39.5 and 37.5 at 3
months of age, to 19 and 18.5 at 12 months of age, respectively.
This observation suggests that while the activity levels in both
genotypes decline to similar levels over time, we sampled elevated
plus maze behavior at an age where 5LO-KO mice had
diminished locomotor activity but WT mice did not. Indeed,
previous work demonstrates that there is an overall decline in
locomotion as a function of aging in mice, and it has also been
reported knockout of 5LO does not alter diurnal or nocturnal
rodent activity [16,17]. Importantly, the significant differences we
observed in 5LO-KO at 6 months in percentage of time spent in
closed and open arm were reproduced at 12 months of age.
Taken together, our findings support the new hypothesis that in
the central nervous system the 5LO products of the arachidonic
acid metabolism (i.e, 5-HETEs, leukotrienes), among other
activities, may have an inhibitory action on mechanisms involved
in the development of anxiety-like symptoms.
The observation that 5LO-KO leads to an age-dependent
increase in anxiety-like behavior is in contrast with a previous
paper where a reduction in this type of behavior was reported [9].
In their study, the authors used mice aged 2–3 months and found
significant increases in open arm entries and time spent, while also
finding reduction in time spent in the closed arms. Though we
found no differences in elevated plus maze anxiety-like behavior
between WT and 5LO-KO mice aged 3 months, this observation
could be because Uz and colleagues used male mice in their
behavioral experiments while in our study we used female mice. It
is possible that a difference in gender might account for such a
discrepancy. It has been shown that the production of leukotrienes,
the downstream metabolites of 5LO, is substantially lower in
whole blood and neutrophils in human males compared to
females, which has been shown to result from testosterone-
influenced differences in sub-cellular localization of 5-LO [18,19].
Such a difference in 5LO efficiency is also thought to underlie
gender-based differences in the therapeutic response of 5LO
inhibitors [20]. Therefore, the genetic absence of 5LO may alter
downstream signaling pathways differently in male and female
mice.
The fact that the anxiety-like behavior increased in adulthood
and at an age thought to represent late adulthood or early
senescence in mice, is particularly intriguing given that we found
no difference in the adolescent mice. Thus, it is possible to
speculate that the permanent absence of 5LO metabolites in these
mice influences brain circuitry which, while not observable at a
young age, manifests in adulthood and is responsible for the
altered phenotype. Interestingly, a polymorphism in the 5LO gene
has been described that influences endogenous 5LO content and
Figure 3. Elevated plus maze behavior in 12 mo old mice. Percentage of total entries into the closed arm (A), open arm (B), total arm entries
(C) and percentage of total time spent in closed (D) and open arm (E). 5LO-KO mice (closed arms) entered the closed arms more and entered open
arms less than wild type (WT) animals (open arms). 5LO-KO animals also spent more time in the closed arm and less time in the open arm than WT
mice. No differences in total arm entries were noted. (WT, n=4, 5LO-KO, n=6).
doi:10.1371/journal.pone.0029448.g003
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work has also implicated different polymorphisms in a downstream
enzyme in the 5LO pathway that may be protective against
depression, but only in women [22]. Furthermore, 5LO pathway
inhibitors, while generally well tolerated, have been recently
shown to have adverse side-effects including an increase in
anxiousness in post-market surveillance. Given this emerging
evidence, it is possible that an interaction between gender and
5LO and 5LO pathway polymorphisms could alter an individual’s
susceptibility to anxiety behavior.
In conclusion, our work demonstrates that knockout of 5LO
leads to an age-dependent increase in anxiety-like behavior in
female mice. Future work must further investigate the mechanism
of these behavioral alterations and establish the role of 5LO in
mediating the anxiety phenotype. Successful accomplishment of
this task could lead to novel therapeutic strategies aimed at
mitigating the symptoms of anxiety disorders.
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